Similar articles

• SEOM clinical practice guideline: management and prevention of febrile neutropenia in adults with solid tumors (2018).

  Carmona-Bayonas A, Jimenez-Fonseca P, de Castro EM, Mata E, Biosca M, Custodio A, Espinosa J, Vázquez EG, Henao F, Ayala de la Peña F. Carmona-Bayonas A, et al. Clin Transl Oncol. 2019 Jan;21(1):75-86. doi: 10.1007/s12094-018-1983-4. Epub 2018 Nov 23. Clin Transl Oncol. 2019. PMID: 30470991 Free PMC article.
• Accuracy of the Multinational Association of Supportive Care in Cancer (MASCC) and Clinical Index of Stable Febrile Neutropenia (CISNE) scores for predicting serious complications in adult patients with febrile neutropenia: A systematic review and meta-analysis.

  Zheng B, Toarta C, Cheng W, Taljaard M, Reaume N, Perry JJ. Zheng B, et al. Crit Rev Oncol Hematol. 2020 May;149:102922. doi: 10.1016/j.critrevonc.2020.102922. Epub 2020 Mar 3. Crit Rev Oncol Hematol. 2020. PMID: 32244162
• Calculated decisions: MASCC Risk Index for febrile neutropenia.

  Taylor J. Taylor J. Emerg Med Pract. 2018 Jan 2;20(Suppl 1):3-4. Emerg Med Pract. 2018. PMID: 29323859 No abstract available.
• [Infections associated with hematologic diseases].

  Akiyama N. Akiyama N. Rinsho Ketsueki. 2014 Oct;55(10):2208-20. Rinsho Ketsueki. 2014. PMID: 25297789 Review. Japanese. No abstract available.
• Application of the MASCC and CISNE Risk-Stratification Scores to Identify Low-Risk Febrile Neutropenic Patients in the Emergency Department.

  Coyne CJ, Le V, Brennan JJ, Castillo EM, Shatsky RA, Ferran K, Brodine S, Vilke GM. Coyne CJ, et al. Ann Emerg Med. 2017 Jun;69(6):755-764. doi: 10.1016/j.annemergmed.2016.11.007. Epub 2016 Dec 29. Ann Emerg Med. 2017. PMID: 28041827